image
Healthcare - Biotechnology - NASDAQ - US
$ 1.09
1.87 %
$ 26.1 M
Market Cap
-1.82
P/E
BALANCE SHEET
1.47 M ASSETS
-79.82%
4.47 M LIABILITIES
305.26%
-3 M EQUITY
-48.68%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition RenovoRx, Inc.
image
Current Assets 1.47 M
Cash & Short-Term Investments 1.17 M
Receivables 0
Other Current Assets 293 K
Non-Current Assets 0
Long-Term Investments 0
PP&E 0
Other Non-Current Assets 0
Current Liabilities 1.18 M
Accounts Payable 561 K
Short-Term Debt 0
Other Current Liabilities 614 K
Non-Current Liabilities 3.29 M
Long-Term Debt 0
Other Non-Current Liabilities 3.29 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019
ASSETS
Cash & Cash Equivalents 1.2 6.4 15.2 1.8 2.1
Short Term Investments 0 2.0 0 0 0
Receivables 0 0 0 0 0
Inventory 0 0 0 0 0
Other Current Assets 0.3 0.8 1.1 0.1 0.2
Total Current Assets 1.5 7.3 16.3 1.9 2.3
PP&E 0 0 6 K 0 0
Intangible Assets 0 0 0 0 0
Goodwill 0 0 0 0 0
Long Term Investments 0 0 0 0 0
Other Long Term Assets 0 0 0 4 K 4 K
Other Assets 0 0 0 0 0
Total Assets 1.5 7.3 16.3 1.9 2.3
LIABILITIES
Accounts Payable 0.6 0.5 0.5 0.2 0.5
Short Term Debt 0 0 0 2.8 0
Other Current Liabilities 0.6 0.6 0.4 1.2 0.3
Total Current Liabilities 1.2 1.1 0.9 4.1 0.8
Long Term Debt 0 0 0 23 K 0
Deferred Tax Income 0 0 0 0 0
Other Liabilities 3.3 0 0 12.5 0
Total Liabilities 4.5 1.1 0.9 16.6 13.2
EQUITY
Common Stock 1 K 1 K 1 K 1 K 1 K
Retained Earnings (41.4) (31.2) (21.3) (15.0) (11.2)
Other Accumulative Comprehensive Income/Loss 0 17 K (16.3) 12.5 K 12.4 K
Total Equity (3.0) 6.2 15.3 (14.7) (10.9)
Total Liabilities and Equity 1.5 7.3 16.3 1.9 2.3
SHARES OUTSTANDING
Common Shares Outstanding 10.3 9.1 8.9 8.7 8.7